Vanguard Personalized Indexing Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
28,359
+430
+2% +$11.3K 0.01% 944
2026
Q1
$593K Buy
27,929
+4,663
+20% +$93.2K 0.01% 1218
2025
Q4
$379K Buy
23,266
+447
+2% +$6.75K ﹤0.01% 1396
2025
Q3
$267K Buy
22,819
+678
+3% +$8.84K ﹤0.01% 1556
2025
Q2
$256K Buy
22,141
+9,928
+81% +$90.5K ﹤0.01% 1517
2025
Q1
$107K Buy
+12,213
New +$154K ﹤0.01% 1605
2024
Q4
Sell
-13,919
Closed -$314K 1873
2024
Q3
$314K Buy
+13,919
New +$288K 0.01% 1323
2024
Q2
Sell
-8,199
Closed -$308K 1748
2024
Q1
$308K Sell
8,199
-730
-8% -$32.1K 0.01% 1251
2023
Q4
$500K Sell
8,929
-9,655
-52% -$420K 0.01% 1004
2023
Q3
$767K Sell
18,584
-492
-3% -$25.6K 0.02% 695
2023
Q2
$1.07M Sell
19,076
-1
-0% -$54 0.03% 541
2023
Q1
$1.06M Buy
19,077
+1,683
+10% +$78.6K 0.04% 499
2022
Q4
$634K Buy
+17,394
New +$569K 0.03% 709
2022
Q3
Sell
-17,461
Closed -$790K 1311
2022
Q2
$790K Buy
17,461
+14,389
+468% +$747K 0.04% 575
2022
Q1
$234K Buy
+3,072
New +$269K 0.01% 1066
2021
Q3
Sell
-1,101
Closed -$216K 1056
2021
Q2
$216K Buy
+1,101
New +$199K 0.02% 867

Other funds holding TXG

Vanguard Personalized Indexing Management's TXG Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its 10x Genomics (TXG) stake by 1.5% in Q2 2026, buying an estimated $11.3K and bringing the position to 28,359 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #944.

Vanguard Personalized Indexing Management first reported a position in TXG in Q2 2021 and has held it in 16 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Vanguard Personalized Indexing Management held 28,359 shares of 10x Genomics worth $1.09M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 430 10x Genomics shares in Q2 2026, an estimated $11.3K.
  • 10x Genomics made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #944 holding.
  • Vanguard Personalized Indexing Management first reported a position in 10x Genomics in Q2 2021 and has held it in 16 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.